SYNTHESIS OF NEW N-HYDROXYPHENYL AND TOLYL DERIVATIVES OF PYRIMIDINE-4(1H) –ONE WITH ANTI-INFLAMMATORY ACTIVITY


Cite item

Full Text

Abstract

In their structure pyrimidin-4-one derivatives are similar to the endogenous nitrogen bases. This makes it possible to predict a wide range of pharmacological activities characteristic for them. The compounds of this series exhibit neurotropic, immunotropic, actoprotective, hypotensive, antihypoxic, anti-infl ammatory and antioxidant activity. Within this framework, the search for and creation of highly effective and safe anti-infl ammatory drugs in the series of N-arylpyrimidin-4(1H)-one is of great current interest.The aim of the work is to carry out predictive studies and targeted synthesis of N-substituted derivatives of pyrimidine-4(1H)-one with anti-infl ammatory activity, as well as toconfi rm the validity of their molecular construction by the results of pharmacological tests.Materials and methods. The research was carried out using the logical-structural approach and information technologies. The computer analysis of biological activity was carried out by the PASS program. Synthesis of the target compounds was carried out using a modifi ed procedure. The structure of the synthesized compounds was confi rmed by 1H NMR, IR and UV spectroscopy. The investigation of the anti-infl ammatory effect of the synthesized compounds was carried out on the model of acute aseptic infl ammation. The synthesized substances were injected intraperitoneally, the magnitude of the edema was the criterion for evaluating the anti-infl ammatory activity.Results and discussion. In the course of the research on the basis of the logico-structural approach, hydroxyphenyl and alkyl derivatives of pyrimidin-4(1H)-one with anti-infl ammatory properties were validated. A preliminary analysis of the pharmacological properties of the predicted structures was carried out using the PASS program and the most promising compounds were selected. To synthesize the tolyl and hydroxyphenyl derivatives of pyrimidin-4(1H)-one, a modifi ed procedure was used. Its essence consists in the use of catalytic amounts of dimethylsulfoxide in order to increase the nucleophilicity of the amine component of the reaction. In order to confi rm the reliability and expediency of the molecular construction, the antiexudative activity of the target compounds was studied.Conclusion. The results of pharmacological studies indicate the prospect of searching for and creating new biologically active compounds having anti-infl ammatory activity among the tolyl and hydroxyphenyl derivatives of pyrimidin-4(1H)-one.

About the authors

I. P. Kodonidi

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: kodonidiip@mail.ru

O. O. Novikov

Medical Institute “Belgorod State National Research University”, Russian Ministry of Health

Email: fake@neicon.ru

S. A. Kuleshova

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: fake@neicon.ru

Ju. I. Rjabukhin

Astrakhan State Technical University

Email: ryabukhin@astu.org

S. S. Shatokhin

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: Shatohin.stanislav95@yandex.ru

A. V. Ivchenko

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: fake@neicon.ru

M. I. Kodonidi

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: fake@neicon.ru

O. M. Zhilina

Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University

Email: sharenko_oks@mail.ru

References

  1. Кодониди И.П., Оганесян Э.Т., Глушко А.А., Тюренков И.Н., Багметова В.В., Золотых Д.С., Погребняк А.В. Молекулярное конструирование и целенаправленный синтез N-замещенных производных 4-оксо-1,4-дигидропиримидина на основе тормозных нейромедиаторов // Хим.-фармац. журн. 2009. Т.43. №10. С. 32–39.
  2. Гражданцева Н.Н., Самотруева М.А., Тюренков И.Н., Хлебцова Е.Б., Оганесян Э.Т., Кодониди И.П., Золотых Д.С. Дозозависимость иммунотропных свойств производных дигидропиримидина // Фармация. 2010. №5. С. 42–44.
  3. Кодониди И.П. Молекулярное конструирование N-замещенных производных 1,3-диазинона-4 // Фармация. 2010. №1. С. 36–40.
  4. Pedro Soares, Raquel Costa, Hugo J.C. Froufe, Ricardo C. Calhelha, Daniela Peixoto, Isabel C.F.R. Ferreira, Rui M.V. Abreu, Raquel Soares, Maria-João R.P. Queiroz1-Aryl-3-ureas as VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modelling Studies // BioMed Research International. 2013. Vol. 2013. 9 p. doi: 10.1155/2013/154856
  5. Kodonidi I.P., Oganesyan E.T., Zolotyh D.S. Antiallergic and immunomodulating activity of N-of 4-. XXXVIIIth Meeting European Histamine Research Society: Fulda, Germany, 13–16 May 2009. Р. 59.
  6. Оганесян Э.Т., Кодониди И.П., Кулешова С.А., Макарова Л.М., Жогло Е.Н., Бандура А.Ф., Сочнев В.С. Целенаправленный синтез производных 1,4-дигидро-4-оксопиримидина, обладающих актопротекторной активностью // Вопросы биологической, медицинской и фармацевтической химии. 2013. №3. С. 21–27.
  7. Sheorey R.V., Thangathiruppathy A., Alagarsamy V. .Antibacterial and antimycobacterial activities of 2,3-disubstituted quinazolin-4-ones // IJCPS. 2014. Vol 2(1). P. 571–575.
  8. Alagarsamy V., Pathak U.S. Synthesis and antihypertensive activity of novel 3-benzyl-2- substituted-3-H-triazoloquinazoline-9-ones // Bioorg. Med. Chem. 2007. Vol. 15. P. 3457–3462. doi: 10.1016/j.bmc.2007.03.007
  9. Pankaj S. Salunkhe Study of analgesic & anti–infl ammatory evaluation of some 2,3-dihydroquinozoline-4-one derivatives // Intern. J. of Pharma Research and Development. 2010. Vol 2. №1. Р. 1–5.
  10. Amir M., Javed S., Kumar H. Pyrimidine as Antiinfl ammatory Agent: A Review // Indian J. of Pharm. Sciences. May-June 2007. P. 337-343. doi: 10.4103/0250-474X.34540
  11. Panda S.S., Chowdary P.V. Synthesis of Novel Indolyl-Pyrimidine Antiinfl ammatory, Antioxidant and Antibacterial Agents // Indian J. of Pharm. Sciences. 2008. Vol. 70. No. 2. P. 208–215. doi: 10.4103/0250-474X.41457
  12. Alagarsamy V., Shankar D., Solomon V.R., Sheorey R.V., Parthiban P. Synthesis and pharmacological evalution of 3-cyclohexyl-2-substituted hydrazine-3H-quinazolin-4-ones as analgesic and anti-infl ammatory agents // Acta Pharm. 2009. N. 59. P. 75–88. doi: 10.2478/v10007-009-0004-0
  13. Alagarsamy V., Gopal M., Venkateshperumal R. Synthesis, analgesic, antiinfl amatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4(3H)-ones // Biol. Pharm. Bull. 2003. N 26. P. 1711–1714. doi: 10.1248/bpb.26.1711
  14. Якугаку Дзасси. Изучение синтеза производных 2(IH) – пиридона. 1. Синтез и фармакологические свойства 6-замещенных 2(IH)-пиридонов // J.pharm. Soc. Jap. 1979. Vol. 99. №6. P. 588–597; РЖ Химия. 1980. №11. C. 349.
  15. Щекина Е.Г. Механизмы действия и перспективы применения современных НПВС // Провизор. 2007. №11. С. 38–41.
  16. Yadav M.R., Shirude S.T., Parmar A., Balaraman R., Giridhar R. Synthesis and anti-infl ammatory activity of 2,3-diaryl-4(3H)-Quinazolinones // Chemistry of Heterocyclic Compounds. 2006. Vol. 42. Is. 8. P. 1038–1045.
  17. Кулешова С.А., Кодониди И.П., Ивашев М.Н., Нечволод Д.А. Синтез и фармакология производных 4-оксо-1,4-дигидропиримидина // Разработка, исследование и маркетинг новой фармацевтической продукции: сб. науч. тр./ Пятигорск. ГФА. Пятигорск, 2007. Вып. 62. С. 491–492.
  18. Оганесян Э.Т., Кодониди И.П., Лысенко Т.А., Ивченко А.В., Золотых Д.С., Бичеров А.В. Исследование противовоспалительной активности производных хиназолинона-4 и их ациклических предшественников // Биомедицина. 2010. №5. 105–107.
  19. Кодониди И.П., Давыдов В.С., Смирнова Л.П. Синтез нестероидных противовоспалительных средств и изучение антиэкссудативной активности N-арилпроизводных 4-оксопиримидина // Экология и здоровье: Сб. науч. тр. Ессентуки: Ассоциация мед. центров «Юнеско», 2009. Вып. №13. С. 73–78.
  20. Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Гриф и К, 2012. Ч. 1. 944 с.
  21. Сернов Л.Н., Гацура В.В. Элементы экспериментальной фармакологии. – М.: Наука, 2000. 352 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Kodonidi I.P., Novikov O.O., Kuleshova S.A., Rjabukhin J.I., Shatokhin S.S., Ivchenko A.V., Kodonidi M.I., Zhilina O.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 67428 от 13.10.2016. 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies